British Journal of Urology · 1991 · 39 citations · 2 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyHepatologyProstate DiseaseHepatic Drug MetabolismHepatic NecrosisHepatocellular CarcinomaHepatocellular NecrosisHepatotoxicity MechanismsLiver DiseaseHepatocellular Carcinoma TreatmentHepatocellular Injury MechanismsHepatocellular Liver InjuryHepatocellular ToxicityLiver Toxicity AssessmentLiver Toxicity MechanismsLong-term Medication Use
Cyproterone acetate (CPA) is a widely used drug in the treatment of advanced prostatic carcinoma. Although it is generally well tolerated, liver toxicity has been recognised as a complication of long-term use. We report 3 patients with severe hepatocellular damage due to CPA therapy, 2 with fatal fulminant hepatitis.
2
Fatal hypoglycaemia in a diabetic.
Winkler Jl · PubMed · 1948 · 135 citations